WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A REVIEW STUDY OF PARPATI KALPANA: AN EFFECTIVE PHARMACEUTICAL FORM

Dr. Jyoti Sherawat*, Dr. Dilip Wadodkar, Dr. Chattragun Lagad

Abstract

Rasashastra deals with Parada and it is considered to be the heart of Rasashastra. Ayurveda, incorporates many of the Herbo-mineralmetallic pharmaceutical preparations prepared out of the Parada namely Khalviya Rasayana, Parpati Rasayana, Pottali Rasayana and Kupipakwa Rasayana respectively. Parpati Rasayana Kalpanas are the most popular among the Processing’s of Mercury and are widely used. These are therapeutically effective mineral and Metallic formulations; including both Sagandha and Nirgandha Parada Yukta yogas. The Name “Parpati” is given to this preparation because of its form and the method of preparation as it is made in the form of thin flakes (Papada). Parpati is a thin Flake like preparation consisting of Parada, Gandhaka and other drugs which are developed from Parada. Parpati Rasayanas have high therapeutic value, potency, less toxicity and cost effective preparations. So, considering detailed review of Parpati Kalpana preparations is done. So, in this paper an honest attempt has been made to have a systematic overview of Parpati Kalpana.

Keywords: Rasashastra, Parada, Gandhaka, Parpati Kalpana.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More